| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Stefano Frara, Matteo Acanfora, Vincenzo Franzese, Maria Luisa Brandi, Marco Losa, Andrea Giustin. Novel approach to bone comorbidity in resistant acromegaly. Pituitary. 2024-11-21. PMID:39570564. |
among them, acromegaly osteopathy and fragility (vertebral and hip) fractures have emerged as frequent and precocious events in the natural history of the disease, being correlated with longer disease duration and higher growth hormone (gh) levels, accounting for patients' reported poor quality of life, physical performance and other life-impacting complications. |
2024-11-21 |
2024-11-23 |
Not clear |
| Marta Araujo-Castro, Betina Biagetti, Edelmiro Menéndez Torre, Iría Novoa-Testa, Fernando Cordido, Eider Pascual Corrales, Víctor Rodríguez Berrocal, Fernando Guerrero-Pérez, Almudena Vicente, Juan Carlos Percovich, Rogelio García Centeno, Laura González, María Dolores Ollero García, Ana Irigaray Echarri, María Dolores Moure Rodríguez, Cristina Novo-Rodríguez, María Calatayud, Rocío Villar, Ignacio Bernabéu, Cristina Alvarez-Escola, Pamela Benítez Valderrama, Carmen Tenorio-Jimenéz, Pablo Abellán Galiana, Eva Venegas Moreno, Inmaculada González Molero, Pedro Iglesias, Concepción Blanco, Fernando Vidal-Ostos De Lara, Paz de Miguel, Elena López Mezquita, Felicia Hanzu, Iban Aldecoa, Cristina Lamas, Silvia Aznar, Anna Aulinas, Anna Calabrese, Paola Gracia, José María Recio-Córdova, Mariola Aviles, Diego Asensio-Wandosel, Miguel Sampedro, Ignacio Ruz-Caracuel, Rosa Camara, Miguel Paja, Carmen Fajardo-Montañana, Mónica Marazuela, Manel Puig-Doming. Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases. The Journal of clinical endocrinology and metabolism. vol 109. issue 12. 2024-11-17. PMID:38436926. |
few data exist about the clinical course of acromegaly, surgical and medical outcomes in patients with gh- and prolactin cosecreting pituitary adenomas (gh&prl-pas). |
2024-11-17 |
2024-11-22 |
Not clear |
| Ana Irigaray Echarri, M Dolores Ollero García-Agulló, José Jorge Ortez Toro, Idoya Zazpe Ceno. Endothelial dysfunction and vascular abnormalities in acromegaly. A case report. Neurocirugia (English Edition). 2024-10-30. PMID:39477091. |
in patients with acromegaly, the pleiotropic effects of gh and igf-1 have been associated with the development of endothelial dysfunction and vascular abnormalities. |
2024-10-30 |
2024-11-02 |
Not clear |
| Kento Takahara, Ryota Tamura, Erika Isomura, Yohei Kitamura, Ryo Ueda, Masahiro Tod. Variable anatomical features of acromegaly in the nasal cavity and paranasal sinuses: implications for endoscopic endonasal transsphenoidal surgery. Acta neurochirurgica. vol 166. issue 1. 2024-10-15. PMID:39404864. |
growth hormone (gh)-secreting pituitary neuroendocrine tumors (pitnets) are the most common cause of acromegaly. |
2024-10-15 |
2024-10-17 |
Not clear |
| Diego Ferone, Pamela Freda, Laurence Katznelson, Federico Gatto, Pinar Kadioğlu, Pietro Maffei, Jochen Seufert, Julie M Silverstein, Joanna L Spencer-Segal, Elena Isaeva, Alexander Dreval, Maria Harrie, Agneta Svedberg, Fredrik Tiber. Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1. The Journal of clinical endocrinology and metabolism. 2024-10-08. PMID:39378125. |
acromegaly, characterized by excessive growth hormone (gh) and insulin-like growth factor-1 (igf-1), impacts quality of life (qol) and mortality. |
2024-10-08 |
2024-10-11 |
Not clear |
| Jinlin Wang, Zaidong Zhang, Yaru Shi, Wentao Wang, Yanli Hu, Zonglan Che. Secondary diabetes mellitus in acromegaly: Case report and literature review. Medicine. vol 103. issue 39. 2024-09-27. PMID:39331882. |
acromegaly, predominantly resulting from a pituitary adenoma, is marked by excessive secretion of growth hormone (gh) and insulin-like growth factor-1 (igf-1). |
2024-09-27 |
2024-10-01 |
Not clear |
| Iulia Stefania Plotuna, Melania Balas, Ioana Golu, Daniela Amzar, Roxana Popescu, Ligia Petrica, Adrian Vlad, Daniel Luches, Daliborca Cristina Vlad, Mihaela Vla. The Use of Kidney Biomarkers, Nephrin and KIM-1, for the Detection of Early Glomerular and Tubular Damage in Patients with Acromegaly: A Case-Control Pilot Study. Diseases (Basel, Switzerland). vol 12. issue 9. 2024-09-27. PMID:39329880. |
acromegaly is a rare disorder caused by excessive growth hormone (gh) secreted from a pituitary tumor. |
2024-09-27 |
2024-09-29 |
Not clear |
| Sabrina Chiloiro, Flavia Costanza, Antonella Giampietro, Amato Infante, Pier Paolo Mattogno, Flavia Angelini, Consolato Gullì, Liverana Lauretti, Mario Rigante, Alessandro Olivi, Laura De Marinis, Francesco Doglietto, Antonio Bianchi, Alfredo Pontecorv. GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study. Frontiers in endocrinology. vol 15. 2024-09-16. PMID:39280003. |
gh receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study. |
2024-09-16 |
2024-09-18 |
Not clear |
| Girish Pathak, Swati Vijapurkar, Jitendra V Kalbande, Daliboina T Chandana, Gade Sandee. Growth Hormone-Secreting Pituitary Adenoma and Difficult Airway: Awake Oral Fiberoptic Intubation Approach. Cureus. vol 16. issue 7. 2024-09-02. PMID:39219953. |
acromegaly is a rare endocrine disorder characterized by excessive growth hormone (gh) secretion, usually due to a pituitary adenoma. |
2024-09-02 |
2024-09-04 |
Not clear |
| Girish Pathak, Swati Vijapurkar, Jitendra V Kalbande, Daliboina T Chandana, Gade Sandee. Growth Hormone-Secreting Pituitary Adenoma and Difficult Airway: Awake Oral Fiberoptic Intubation Approach. Cureus. vol 16. issue 7. 2024-09-02. PMID:39219953. |
acromegaly, resulting from excessive gh secretion, often leads to difficult airway management, cardiovascular complications, and metabolic abnormalities. |
2024-09-02 |
2024-09-04 |
Not clear |
| Ioana Balinisteanu, Lavinia Caba, Andreea Florea, Roxana Popescu, Laura Florea, Maria-Christina Ungureanu, Letitia Leustean, Eusebiu Vlad Gorduza, Cristina Pred. Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder. Current issues in molecular biology. vol 46. issue 8. 2024-08-28. PMID:39194755. |
acromegaly is a rare endocrine disorder characterized by the excessive production of growth hormone (gh) in adulthood. |
2024-08-28 |
2024-08-30 |
Not clear |
| Mette H Jensen, Lærke S Gasbjerg, Kirsa Skov-Jeppesen, Jens C B Jacobsen, Steen S Poulsen, Cuiqi Zhou, Ruta Jakubauskaite, Frantz R Poulsen, Christian Bonde, Mahmoud Albarazi, Bo Halle, Charlotte B Christiansen, Samra J Sanni, Sarah Byberg, Bjørn Hoe, Jens J Holst, Flemming Dela, Aase K Rasmussen, Filip K Knop, Mai C Arlien-Søborg, Shlomo Melmed, Jens Otto L Jørgensen, Marianne S Andersen, Bolette Hartmann, Marianne C Klose, Ulla Feldt-Rasmussen, Alexander H Sparre-Ulrich, Mette M Rosenkild. GIP receptor antagonism eliminates paradoxical growth hormone secretion in some patients with acromegaly. The Journal of clinical endocrinology and metabolism. 2024-08-22. PMID:39172542. |
about 30% of patients with active acromegaly experience paradoxically increased growth hormone (gh) secretion during the diagnostic oral glucose tolerance test (ogtt). |
2024-08-22 |
2024-08-25 |
Not clear |
| Kyungwon Kim, Yeongmin Kim, Se Hoon Kim, Ju Hyung Moon, Eui Hyun Kim, Eun Jig Lee, Chang-Myung Oh, Cheol Ryong K. Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern. Frontiers in oncology. vol 14. 2024-08-14. PMID:39139281. |
this study investigated differential gene expression between granulation patterns in growth hormone (gh)-secreting pituitary tumors, aiming to elucidate novel transcriptomes that explain clinical variances in patients with acromegaly. |
2024-08-14 |
2024-08-16 |
Not clear |
| Zeinab Dabbous, Zaina Rohani, Abeer Kaled Abdalrubb, Yaman Alkailani, Rosario Pivonello, Tarik Elhad. Rapid Resolution of Recalcitrant Headache With Pasireotide in an Adult Patient With Acromegaly. JCEM case reports. vol 2. issue 8. 2024-08-12. PMID:39129819. |
acromegaly is a chronic hormonal disorder caused by excessive gh secretion. |
2024-08-12 |
2024-08-14 |
Not clear |
| Shailesh Aggarwal, Sweatha Mani, Abirami Balasubramanian, Keerthana Veluswami, Sudipta Ra. A Review on Coexisting Giants: The Interplay Between Acromegaly and Diabetes Mellitus. Cureus. vol 16. issue 7. 2024-08-09. PMID:39119396. |
acromegaly is a rare disease caused mainly by pituitary adenoma, which results in elevated growth hormone (gh) levels and its primary mediator, insulin-like growth factor (igf-1). |
2024-08-09 |
2024-08-12 |
Not clear |
| Mirjana Doknic, Marko Stojanovic, Dragana Miljic, Mihajlo Milicevi. Medical treatment of acromegaly - When the tumor size matters: A narrative review. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 78. 2024-08-08. PMID:39116789. |
assessment of changes in gh-secreting adenoma volume is often overshadowed by clinicians' focus on gh and igf-i levels during acromegaly treatment. |
2024-08-08 |
2024-08-12 |
Not clear |
| Liu-Han Chen, Tao Xie, Qian Lei, Yan-Rui Gu, Chuan-Zheng Su. A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus-pituitary-thyroid axis. Frontiers in endocrinology. vol 15. 2024-08-06. PMID:39104813. |
in fact, numerous studies of patients with acromegaly have shown that serum levels of gh and insulin-like growth factor-1 (igf-1) may be associated with the onset and progression of tc, although the influences of age, sex, and other risk factors, such as obesity and stress, remain unclear. |
2024-08-06 |
2024-08-08 |
Not clear |
| Ossama Achach, Imane Assarrar, Mohamed Aymane Loukili, Siham Rouf, Hanane Latrec. Cutis verticis gyrata in a patient with acromegaly: an unusual case and review of literature. Dermatology online journal. vol 30. issue 3. 2024-08-01. PMID:39090044. |
acromegaly is a rare systemic syndrome induced by the overproduction of growth hormone (gh) and insulin-like growth factor type one (igf1). |
2024-08-01 |
2024-08-05 |
Not clear |
| Ossama Achach, Imane Assarrar, Mohamed Aymane Loukili, Siham Rouf, Hanane Latrec. Cutis verticis gyrata in a patient with acromegaly: an unusual case and review of literature. Dermatology online journal. vol 30. issue 3. 2024-08-01. PMID:39090044. |
the management of acromegaly associated with cvg depends on controlling the serum levels of gh and igf1. |
2024-08-01 |
2024-08-05 |
Not clear |
| Leticia Marinho Del Corso, Cleo Otaviano Mesa Junior, Vicente Florentino Castaldo Andrade, Solena Ziemer Kusma Fidalski, Cesar Luiz Boguszewsk. Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis. Pituitary. 2024-08-01. PMID:39088137. |
to evaluate clinical, laboratory, radiological, therapeutic, and prognostic characteristics of patients with acromegaly according to the size of the growth hormone (gh)-secreting pituitary adenoma at diagnosis. |
2024-08-01 |
2024-08-03 |
Not clear |